Home › Funds › NEXTBio Capital Management LP › IRON

NEXTBio Capital Management LP position in IRON

DISC MEDICINE INC · Health Care

NEXTBio Capital Management LP reported holding 52,655 shares of IRON (DISC MEDICINE INC) in its Q3 2026 13F filing — a position valued at US$3.4M, representing 1.50% of its reported portfolio and ranking #20 among its reported holdings. NEXTBio Capital Management LP has disclosed IRON holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)52.66K sh
Reported value held$3.45M
Portfolio Weight1.50%
First reportedQ4 2025
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How NEXTBio Capital Management LP's IRON position evolved

NEXTBio Capital Management LP first disclosed a stake in IRON in Q4 2025 at 42,778 shares (US$3.4M). The position peaked in Q2 2026 at 52,655 shares, worth US$3.9M. Across 4 filings, NEXTBio Capital Management LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 52,655 shares valued at US$3.4M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 42.78K $3.40M New
Q1 2026 52.66K $3.37M Add
Q2 2026 52.66K $3.85M Hold
Q3 2026 52.66K $3.45M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IRON and 13F data

IRON (DISC MEDICINE INC) is a Health Care company. 38 other funds we track also report a position in IRON — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$179.2M), Vestal Point Capital, LP (US$113.4M), Frazier Life Sciences Management, L.P. (US$99.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IRON

All IRON fund holders →

FAQ

How long has NEXTBio Capital Management LP held IRON?

NEXTBio Capital Management LP has disclosed IRON holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is NEXTBio Capital Management LP's current position in IRON?

As of Q3 2026, NEXTBio Capital Management LP holds 52.66K shares of IRON (DISC MEDICINE INC), valued at $3.45M, representing 1.50% of its reported portfolio and ranking #20.

Has NEXTBio Capital Management LP been buying or selling IRON?

In the latest 13F filing (Q3 2026), NEXTBio Capital Management LP held unchanged its position in IRON. The position peaked in Q2 2026 at 52.66K shares.

Which other funds hold IRON?

Other major institutional holders of IRON include RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, Frazier Life Sciences Management, L.P., among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.